{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T12:37:14Z","timestamp":1696250234179},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,15]],"date-time":"2012-04-15T00:00:00Z","timestamp":1334448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1748-717x-7-60","type":"journal-article","created":{"date-parts":[[2012,4,15]],"date-time":"2012-04-15T22:13:55Z","timestamp":1334528035000},"source":"Crossref","is-referenced-by-count":12,"title":["Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre"],"prefix":"10.1186","volume":"7","author":[{"given":"Maria C","family":"Wolf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Zehentmayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"H\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Belka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,15]]},"reference":[{"issue":"2","key":"567_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.radonc.2009.02.019","volume":"92","author":"B Berger","year":"2009","unstructured":"Berger B, Belka C: Evidence-based radiation oncology: oesophagus. Radiother Oncol 2009,92(2):276-290. 10.1016\/j.radonc.2009.02.019","journal-title":"Radiother Oncol"},{"key":"567_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1748-717X-6-55","volume":"6","author":"MC Wolf","year":"2011","unstructured":"Wolf MC, Stahl M, Krause BJ, Bonavina L, Bruns C, Belka C, Zehentmayr F: Curative treatment of oesophageal carcinoma: current options and future developments. Radiat Oncol 2011, 6: 55. 10.1186\/1748-717X-6-55","journal-title":"Radiat Oncol"},{"issue":"6","key":"567_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.gassur.2005.05.005","volume":"9","author":"PW Chiu","year":"2005","unstructured":"Chiu PW, Chan AC, Leung SF, Leong HT, Kwong KH, Li MK, Au-Yeung AC, Chung SC, Ng EK: Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005,9(6):794-802. 10.1016\/j.gassur.2005.05.005","journal-title":"J Gastrointest Surg"},{"issue":"10","key":"567_CR4","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2005.04.7118","volume":"25","author":"L Bedenne","year":"2007","unstructured":"Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, et al.: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007,25(10):1160-1168. 10.1200\/JCO.2005.04.7118","journal-title":"J Clin Oncol"},{"issue":"3","key":"567_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJM199707173370304","volume":"337","author":"JF Bosset","year":"1997","unstructured":"Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Ollier JC, Pavy JJ, Mercier M, et al.: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997,337(3):161-167. 10.1056\/NEJM199707173370304","journal-title":"N Engl J Med"},{"issue":"9","key":"567_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1470-2045(05)70288-6","volume":"6","author":"BH Burmeister","year":"2005","unstructured":"Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, et al.: Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005,6(9):659-668. 10.1016\/S1470-2045(05)70288-6","journal-title":"Lancet Oncol"},{"issue":"17","key":"567_CR7","first-page":"1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, et al.: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. Jama 1999,281(17):1623-1627.","journal-title":"Radiation Therapy Oncology Group. Jama"},{"issue":"24","key":"567_CR8","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","volume":"326","author":"A Herskovic","year":"1992","unstructured":"Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992,326(24):1593-1598. 10.1056\/NEJM199206113262403","journal-title":"N Engl J Med"},{"issue":"10","key":"567_CR9","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1200\/JCO.2005.00.034","volume":"23","author":"M Stahl","year":"2005","unstructured":"Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, et al.: Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005,23(10):2310-2317. 10.1200\/JCO.2005.00.034","journal-title":"J Clin Oncol"},{"issue":"6","key":"567_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1200\/JCO.2008.17.0506","volume":"27","author":"M Stahl","year":"2009","unstructured":"Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, Langer P, Engenhart-Cabillic R, Bitzer M, Konigsrainer A, et al.: Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009,27(6):851-856. 10.1200\/JCO.2008.17.0506","journal-title":"J Clin Oncol"},{"issue":"7","key":"567_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1056\/NEJM199608153350702","volume":"335","author":"TN Walsh","year":"1996","unstructured":"Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996,335(7):462-467. 10.1056\/NEJM199608153350702","journal-title":"N Engl J Med"},{"issue":"3","key":"567_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","volume":"8","author":"V Gebski","year":"2007","unstructured":"Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007,8(3):226-234. 10.1016\/S1470-2045(07)70039-6","journal-title":"Lancet Oncol"},{"issue":"7","key":"567_CR13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00066-010-2137-y","volume":"186","author":"M Wolf","year":"2010","unstructured":"Wolf M, Zehentmayr F, Niyazi M, Ganswindt U, Haimerl W, Schmidt M, Holzel D, Belka C, et al.: Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer. Strahlentherapie und Onkologie . Organ der Deutschen Rontgengesellschaft 2010,186(7):374-381.","journal-title":"Organ der Deutschen Rontgengesellschaft"},{"key":"567_CR14","doi-asserted-by":"crossref","unstructured":"Wong R, Malthaner R: Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 2006, (1):CD002092.","DOI":"10.1002\/14651858.CD002092.pub2"},{"issue":"7","key":"567_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","volume":"12","author":"KM Sjoquist","year":"2011","unstructured":"Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, Gebski V: Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. The lancet oncology 2011,12(7):681-692. 10.1016\/S1470-2045(11)70142-5","journal-title":"The lancet oncology"},{"issue":"1","key":"567_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ijc.11029","volume":"105","author":"AP Polednak","year":"2003","unstructured":"Polednak AP: Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. International journal of cancer Journal international du cancer 2003,105(1):98-100.","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"Suppl 5","key":"567_CR17","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1136\/gut.50.suppl_5.v1","volume":"50","author":"WH Allum","year":"2002","unstructured":"Allum WH, Griffin SM, Watson A, Colin-Jones D: Guidelines for the management of oesophageal and gastric cancer. Gut 2002,50(Suppl 5):v1-23.","journal-title":"Gut"},{"issue":"3","key":"567_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2967\/jnumed.107.047787","volume":"49","author":"JW Fletcher","year":"2008","unstructured":"Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avril N, et al.: Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008,49(3):480-508. 10.2967\/jnumed.107.047787","journal-title":"J Nucl Med"},{"issue":"3","key":"567_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bjc.6604200","volume":"98","author":"EP van Vliet","year":"2008","unstructured":"van Vliet EP, Heijenbrok-Kal MH, Hunink MG, Kuipers EJ, Siersema PD: Staging investigations for oesophageal cancer: a meta-analysis. British journal of cancer 2008,98(3):547-557. 10.1038\/sj.bjc.6604200","journal-title":"British journal of cancer"},{"issue":"4","key":"567_CR20","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/S0003-4975(02)03875-4","volume":"74","author":"MB Wallace","year":"2002","unstructured":"Wallace MB, Nietert PJ, Earle C, Krasna MJ, Hawes RH, Hoffman BJ, Reed CE: An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy\/laparoscopy. The Annals of thoracic surgery 2002,74(4):1026-1032. 10.1016\/S0003-4975(02)03875-4","journal-title":"The Annals of thoracic surgery"},{"issue":"10","key":"567_CR21","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2","volume":"83","author":"SS Devesa","year":"1998","unstructured":"Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998,83(10):2049-2053. 10.1002\/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2","journal-title":"Cancer"},{"issue":"1","key":"567_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1245\/ASO.2005.12.025","volume":"13","author":"SR DeMeester","year":"2006","unstructured":"DeMeester SR: Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol 2006,13(1):12-30. 10.1245\/ASO.2005.12.025","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"567_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/jnci\/dji024","volume":"97","author":"H Pohl","year":"2005","unstructured":"Pohl H, Welch HG: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005,97(2):142-146. 10.1093\/jnci\/dji024","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"567_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 2008,58(2):71-96. 10.3322\/CA.2007.0010","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"567_CR25","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMra035010","volume":"349","author":"PC Enzinger","year":"2003","unstructured":"Enzinger PC, Mayer RJ: Esophageal cancer. N Engl J Med 2003,349(23):2241-2252. 10.1056\/NEJMra035010","journal-title":"N Engl J Med"},{"issue":"5-6","key":"567_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/sj.bjc.6690429","volume":"80","author":"K Dolan","year":"1999","unstructured":"Dolan K, Sutton R, Walker SJ, Morris AI, Campbell F, Williams EM: New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer 1999,80(5-6):834-842.","journal-title":"Br J Cancer"},{"issue":"3","key":"567_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L","volume":"92","author":"E Bollschweiler","year":"2001","unstructured":"Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH: Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001,92(3):549-555. 10.1002\/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L","journal-title":"Cancer"},{"issue":"4","key":"567_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/COC.0b013e3181917158","volume":"32","author":"DT Chang","year":"2009","unstructured":"Chang DT, Chapman C, Shen J, Su Z, Koong AC: Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis. American journal of clinical oncology 2009,32(4):405-410. 10.1097\/COC.0b013e3181917158","journal-title":"American journal of clinical oncology"},{"issue":"2","key":"567_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0304-3835(99)00223-2","volume":"144","author":"K Fukuzawa","year":"1999","unstructured":"Fukuzawa K, Noguchi Y, Yoshikawa T, Saito A, Doi C, Makino T, Takanashi Y, Ito T, Tsuburaya A: High incidence of synchronous cancer of the oral cavity and the upper gastrointestinal tract. Cancer Lett 1999,144(2):145-151. 10.1016\/S0304-3835(99)00223-2","journal-title":"Cancer Lett"},{"issue":"3","key":"567_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.radonc.2005.07.004","volume":"77","author":"S Welz","year":"2005","unstructured":"Welz S, Schmid A, Hehr T, Schulze K, Feldmann HJ, Budach W, Bamberg M, Belka C: Treatment-outcome for synchronous head-and-neck and oesophageal squamous cell carcinoma. Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology 2005,77(3):267-270. 10.1016\/j.radonc.2005.07.004","journal-title":"Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology"},{"issue":"6","key":"567_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1470-2045(07)70172-9","volume":"8","author":"C Mariette","year":"2007","unstructured":"Mariette C, Piessen G, Triboulet JP: Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007,8(6):545-553. 10.1016\/S1470-2045(07)70172-9","journal-title":"Lancet Oncol"},{"issue":"1","key":"567_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0360-3016(91)90134-P","volume":"20","author":"LR Coia","year":"1991","unstructured":"Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE: Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991,20(1):29-36. 10.1016\/0360-3016(91)90134-P","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"567_CR33","first-page":"277","volume":"15","author":"M Al-Sarraf","year":"1997","unstructured":"Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L, Emami B: Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer. an intergroup study. J Clin Oncol 1997,15(1):277-284.","journal-title":"an intergroup study. J Clin Oncol"},{"issue":"5","key":"567_CR34","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1200\/JCO.20.5.1167","volume":"20","author":"BD Minsky","year":"2002","unstructured":"Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP: INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2002,20(5):1167-1174. 10.1200\/JCO.20.5.1167","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"3","key":"567_CR35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.radonc.2006.01.009","volume":"78","author":"JI Geh","year":"2006","unstructured":"Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R: Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiother Oncol 2006,78(3):236-244. 10.1016\/j.radonc.2006.01.009","journal-title":"Radiother Oncol"},{"issue":"2","key":"567_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1442-2050.2009.00985.x","volume":"23","author":"CK Enestvedt","year":"2010","unstructured":"Enestvedt CK, Perry KA, Kim C, McConnell PW, Diggs BS, Vernon A, O'Rourke RW, Luketich JD, Hunter JG, Jobe BA: Trends in the management of esophageal carcinoma based on provider volume: treatment practices of 618 esophageal surgeons. Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus\/ISDE 2010,23(2):136-144.","journal-title":"Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus\/ISDE"},{"issue":"2","key":"567_CR37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2008.04.022","volume":"73","author":"AL Schwer","year":"2009","unstructured":"Schwer AL, Ballonoff A, McCammon R, Rusthoven K, D'Agostino RB Jr, Schefter TE: Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study. International journal of radiation oncology, biology, physics 2009,73(2):449-455. 10.1016\/j.ijrobp.2008.04.022","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"3","key":"567_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ejca.2006.10.011","volume":"43","author":"DP Cronin-Fenton","year":"2007","unstructured":"Cronin-Fenton DP, Sharp L, Carsin AE, Comber H: Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study. European journal of cancer 2007,43(3):565-575. 10.1016\/j.ejca.2006.10.011","journal-title":"European journal of cancer"},{"issue":"2","key":"567_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/aje\/153.2.114","volume":"153","author":"LM Brown","year":"2001","unstructured":"Brown LM, Hoover R, Silverman D, Baris D, Hayes R, Swanson GM, Schoenberg J, Greenberg R, Liff J, Schwartz A, et al.: Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 2001,153(2):114-122. 10.1093\/aje\/153.2.114","journal-title":"Am J Epidemiol"},{"issue":"4","key":"567_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1053\/j.seminoncol.2004.04.015","volume":"31","author":"B Brenner","year":"2004","unstructured":"Brenner B, Ilson DH, Minsky BD: Treatment of localized esophageal cancer. Seminars in oncology 2004,31(4):554-565. 10.1053\/j.seminoncol.2004.04.015","journal-title":"Seminars in oncology"},{"issue":"2","key":"567_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1634\/theoncologist.9-2-147","volume":"9","author":"M Koshy","year":"2004","unstructured":"Koshy M, Esiashvilli N, Landry JC, Thomas CR Jr, Matthews RH: Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist 2004,9(2):147-159. 10.1634\/theoncologist.9-2-147","journal-title":"Oncologist"},{"key":"567_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1748-717X-5-119","volume":"5","author":"P Palma","year":"2010","unstructured":"Palma P, Conde-Muino R, Rodriguez-Fernandez A, Segura-Jimenez I, Sanchez-Sanchez R, Martin-Cano J, Gomez-Rio M, Ferron JA, Llamas-Elvira JM: The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer. Radiat Oncol 2010, 5: 119. 10.1186\/1748-717X-5-119","journal-title":"Radiat Oncol"},{"key":"567_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1748-717X-5-38","volume":"5","author":"MR Kanakamedala","year":"2010","unstructured":"Kanakamedala MR, Packianathan S, Vijayakumar S: Lack of Cetuximab induced skin toxicity in a previously irradiated field: case report and review of the literature. Radiat Oncol 2010, 5: 38.","journal-title":"Radiat Oncol"},{"key":"567_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1748-717X-5-70","volume":"5","author":"L Du","year":"2010","unstructured":"Du L, Zhou LJ, Pan XJ, Wang YX, Xu QZ, Yang ZH, Wang Y, Liu XD, Zhu MX, Zhou PK: Radiosensitization and growth inhibition of cancer cells mediated by an scFv antibody gene against DNA-PKcs in vitro and in vivo. Radiat Oncol 2010, 5: 70. 10.1186\/1748-717X-5-70","journal-title":"Radiat Oncol"},{"key":"567_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1748-717X-4-66","volume":"4","author":"M Li","year":"2009","unstructured":"Li M, Abdollahi A, Grone HJ, Lipson KE, Belka C, Huber PE: Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model. Radiat Oncol 2009, 4: 66. 10.1186\/1748-717X-4-66","journal-title":"Radiat Oncol"},{"key":"567_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1748-717X-4-47","volume":"4","author":"SF Zerp","year":"2009","unstructured":"Zerp SF, Stoter R, Kuipers G, Yang D, Lippman ME, van Blitterswijk WJ, Bartelink H, Rooswinkel R, Lafleur V, Verheij M: AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK\/JNK pathway and enhances radiation-induced apoptosis. Radiat Oncol 2009, 4: 47. 10.1186\/1748-717X-4-47","journal-title":"Radiat Oncol"},{"key":"567_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1748-717X-5-94","volume":"5","author":"M Scorsetti","year":"2010","unstructured":"Scorsetti M, Navarria P, Mancosu P, Alongi F, Castiglioni S, Cavina R, Cozzi L, Fogliata A, Pentimalli S, Tozzi A, et al.: Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc. Radiat Oncol 2010, 5: 94. 10.1186\/1748-717X-5-94","journal-title":"Radiat Oncol"},{"key":"567_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1748-717X-5-45","volume":"5","author":"TC Huang","year":"2010","unstructured":"Huang TC, Liang JA, Dilling T, Wu TH, Zhang G: Four-dimensional dosimetry validation and study in lung radiotherapy using deformable image registration and Monte Carlo techniques. Radiat Oncol 2010, 5: 45. 10.1186\/1748-717X-5-45","journal-title":"Radiat Oncol"},{"key":"567_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1748-717X-5-35","volume":"5","author":"A Shi","year":"2010","unstructured":"Shi A, Zhu G, Wu H, Yu R, Li F, Xu B: Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 2010, 5: 35. 10.1186\/1748-717X-5-35","journal-title":"Radiat Oncol"},{"key":"567_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1748-717X-5-32","volume":"5","author":"H Yamashita","year":"2010","unstructured":"Yamashita H, Kobayashi-Shibata S, Terahara A, Okuma K, Haga A, Wakui R, Ohtomo K, Nakagawa K: Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol 2010, 5: 32. 10.1186\/1748-717X-5-32","journal-title":"Radiat Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1748-717X-7-60\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T05:09:52Z","timestamp":1548220192000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-7-60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,15]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-7-60","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,15]]},"article-number":"60"}}